PTC Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ. 

CEO
Matthew B. Klein
CEOMatthew B. Klein
Employees
939
Employees939
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
1998
Founded1998
Employees
939
Employees939

PTCT Key Statistics

Market cap
6.77B
Market cap6.77B
Price-Earnings ratio
9.33
Price-Earnings ratio9.33
Dividend yield
Dividend yield
Average volume
1.29M
Average volume1.29M
High today
$85.62
High today$85.62
Low today
$81.89
Low today$81.89
Open price
$84.30
Open price$84.30
Volume
4.29M
Volume4.29M
52 Week high
$85.62
52 Week high$85.62
52 Week low
$35.95
52 Week low$35.95

Stock Snapshot

With a market cap of 6.77B, PTC Therapeutics(PTCT) trades at $82.62. The stock has a price-to-earnings ratio of 9.33.

On 2025-11-25, PTC Therapeutics(PTCT) stock moved within a range of $81.89 to $85.62. With shares now at $82.62, the stock is trading +0.9% above its intraday low and -3.5% below the session's peak.

Trading volume for PTC Therapeutics(PTCT) stock has reached 4.29M, versus its average volume of 1.29M.

Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $85.62 and a low of $35.95.

Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $85.62 and a low of $35.95.

PTCT News

Nasdaq 14h
PTCT Crosses Above Average Analyst Target

In recent trading, shares of PTC Therapeutics Inc (Symbol: PTCT) have crossed above the average analyst 12-month target price of $54.17, changing hands for $55....

PTCT Crosses Above Average Analyst Target
TipRanks 1d
PTC Therapeutics to replace SanDisk in S&P 600 at open on 11/28

17:21 EST PTC Therapeutics (PTCT) to replace SanDisk (SNDK) in S&P 600 at open on 11/28 TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data...

Simply Wall St 2d
PTC Therapeutics: Is the Current Valuation Supported by Recent Momentum?

PTC Therapeutics (PTCT) shares have shown steady gains over the past three months, with the stock up more than 59%. Investors are paying close attention to rece...

PTC Therapeutics: Is the Current Valuation Supported by Recent Momentum?

Analyst ratings

67%

of 15 ratings
Buy
66.7%
Hold
26.7%
Sell
6.7%

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.